No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no linkage between COVID-19 vaccines and sudden deaths among adults post-COVID-19.

The Ministry noted that studies conducted by ICMR and the National Centre for Disease Control (NCDC) affirm that COVID-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects. The incidence of sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-COVID complications. The ICMR and NCDC have been working together to understand the causes behind sudden, unexplained deaths, especially in young adults between the ages of 18 and 45 years.

Akashvani correspondent reports that to explore this, two complementary studies were undertaken using different research approaches-one based on past data and another involving real-time investigation. The findings of the first study have conclusively shown that COVID-19 vaccination does not increase the risk of unexplained sudden death in young adults. The second study is currently being conducted by AIIMS, New Delhi.

Early analysis indicates that heart attacks, or myocardial infarction, continue to be the leading cause of sudden death in this age group. The studies offer a more comprehensive understanding of sudden unexplained deaths in young adults in India. They also reveal that COVID-19 vaccination does not appear to increase the risk, whereas the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths. Scientific experts have reiterated that statements linking COVID vaccination to sudden deaths are false and misleading, not supported by scientific consensus.

Related Posts

Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern

Ozempic and Mounjaro are brand names of the ‘GLP-1 receptor agonist’ class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a…

CDSCO Has Approved 3 Drugs For Weight Management: Govt To Rajya Sabha

New Delhi: Apex drug regulator CDSCO has approved three drugs — Orlistat, Tirzepatide and Semaglutide — for weight loss treatment in the country to be sold in retail on the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern

Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern

CDSCO Has Approved 3 Drugs For Weight Management: Govt To Rajya Sabha

CDSCO Has Approved 3 Drugs For Weight Management: Govt To Rajya Sabha

No spurious drugs were detected in the state during the 2024–25 financial year and so far in 2025–26: CM Manik Saha in Assembly

No spurious drugs were detected in the state during the 2024–25 financial year and so far in 2025–26: CM Manik Saha in Assembly

Chirag Paswan says India working with global bodies on nutraceutical regulations

Chirag Paswan says India working with global bodies on nutraceutical regulations

Peanut Stuck in the Airway of a Child ended up as Emergency

Peanut Stuck in the Airway of a Child ended up as Emergency

Raj HC quashes license cancellation of medical agency for RGHS irregularities

Raj HC quashes license cancellation of medical agency for RGHS irregularities